“There is no evidence of an omicron variation in the United States,” said Francis S. Collins, Director of the US National Institutes of Health (NIH).
The health official also rejected the claims that the virus strain is immune to the current vaccines while saying, “Current vaccines are likely to protect against Omicron.”
On the other hand, the European Centre for Disease Prevention and Control (ECDC) conveyed worries during the weekend while saying, “The omicron variant is the most divergent variant in significant numbers.”
“We are concerned omicron may significantly reduce vaccines' effectiveness and boost the risk of reinfections,” added ECDC.
ECDC also mentioned that the overall risk for the EU/EEA associated with the SARS-COV-2 variant omicron is high to very high.
Given the mixed news and early hours of the Asian trading session on Monday, not to forget Friday’s heavily volatile markets, global markets are yet to respond to the news. However, the risk-on is surely faded.
Read: Covid Special Report: How will worst coronavirus variant seen to date affect markets this week?
© 2000-2024. All rights reserved.
This site is managed by Teletrade D.J. LLC 2351 LLC 2022 (Euro House, Richmond Hill Road, Kingstown, VC0100, St. Vincent and the Grenadines).
The information on this website is for informational purposes only and does not constitute any investment advice.
The company does not serve or provide services to customers who are residents of the US, Canada, Iran, The Democratic People's Republic of Korea, Yemen and FATF blacklisted countries.
Making transactions on financial markets with marginal financial instruments opens up wide possibilities and allows investors who are willing to take risks to earn high profits, carrying a potentially high risk of losses at the same time. Therefore you should responsibly approach the issue of choosing the appropriate investment strategy, taking the available resources into account, before starting trading.
Use of the information: full or partial use of materials from this website must always be referenced to TeleTrade as the source of information. Use of the materials on the Internet must be accompanied by a hyperlink to teletrade.org. Automatic import of materials and information from this website is prohibited.
Please contact our PR department if you have any questions or need assistance at pr@teletrade.global.